Top

Breast Cancer

Published in:

01-01-2007 | Review Article

Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size

Authors: Shoji Oura, Takeshi Tamaki, Issei Hirai, Tatsuya Yoshimasu, Fuminori Ohta, Rie Nakamura, Yoshitaka Okamura

Published in: Breast Cancer | Issue 1/2007

Title: Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size
Authors: Shoji Oura
Takeshi Tamaki
Issei Hirai
Tatsuya Yoshimasu
Fuminori Ohta
Rie Nakamura
Yoshitaka Okamura
Publication date: 01-01-2007
Publisher: Springer Japan
Published in: Breast Cancer / Issue 1/2007
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.2325/jbcs.14.48

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2007

Quality of life of breast cancer patients and types of surgery for breast cancer — Current status and unresolved issues —

Squamous cell carcinoma of the breast in the form of an intracystic tumor

Malignant melanoma originating on the female nipple: A case report

Economic evaluation of the prevention and treatment of breast cancer-present status and open issues

New challenges in the field of breast cancer therapy do we need surgery for the patients with breast cancer?

Clinical trials for sentinel node biopsy in patients with breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer